About Quine Biologics
Quine Biologics is a company based in New York (United States) founded in 2023 by Brett Spurrier. It operates as a B2B. Quine Biologics offers products and services including AI-Designed Antibodies and SE3 De-noising Diffusion. Quine Biologics operates in a competitive market with competitors including Sino Biological, GenScript, Mabtech, Y-Biologics and Epitomics, among others.
- Headquarter New York, United States
- Founders Brett Spurrier
-
Sectors
Technology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Quine Biologics, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Quine Biologics
Quine Biologics offers a comprehensive portfolio of products and services, including AI-Designed Antibodies and SE3 De-noising Diffusion.
Custom AI tools for rapid antibody candidate design and development.
Platform for building antibody CDRs directly into protein epitopes efficiently.
Funding Insights of Quine Biologics
Detailed funding history for Quine Biologics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Quine Biologics
Investment portfolio details for Quine Biologics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Quine Biologics
Detailed financials for Quine Biologics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Quine Biologics Comparisons
Peer comparison for Quine Biologics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Quine Biologics
Quine Biologics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sino Biological, GenScript, Mabtech, Y-Biologics and Epitomics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Reagents and kits are provided for clinical research applications.
|
|
| Locked | Locked | Locked |
Reagents and instruments are provided for life sciences research.
|
|
| Locked | Locked | Locked |
Antibodies and immunoassay kits are developed for research applications.
|
|
| Locked | Locked | Locked |
Developer of antibodies for the treatment of multiple diseases
|
|
| Locked | Locked | Locked |
Monoclonal antibody technology and products are developed by Epitomics.
|
|
| Locked | Locked | Locked |
Technology for antibody-drug conjugation is provided by AbTis.
|
Detailed competitors of Quine Biologics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Quine Biologics
Complete news archive for Quine Biologics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Quine Biologics
Quine Biologics was founded in 2023.
Quine Biologics is headquartered in New York, United States. It is registered at New York, New York, United States.
Quine Biologics uses AI and deep learning technologies to create bespoke antibodies for protein targets, enabling rapid design in hours rather than months. The company focuses on therapeutic-grade solutions for healthcare and biotechnology, serving researchers and clinicians globally. Based in New York, USA, it emphasizes efficiency, cost reduction, and high-quality standards in immunotherapies and personalized medicine.
Quine Biologics's top competitors include Sino Biological, GenScript and Y-Biologics.
Quine Biologics offers AI-Designed Antibodies and SE3 De-noising Diffusion.